Infinium Global Research Premature Ejaculation Treatment Market | Page 2

A latest report has been added to the wide database of Premature Ejaculation Treatment Market by Infinium Global
Research. This report studies the Premature Ejaculation Treatment Market by type (oral therapies; nonselective
serotonin reuptake inhibito, selective serotonin reuptake inhibitor; topical therapies) market status and outlook of
global and major regions, from manufacturers, and end industries. The objective of the study is to identify market
sizes of different segments & countries in recent years and to forecast the values for the next six years. Premature
Ejaculation Treatment Market provides opportunities in micro markets for stakeholders to invest along with the
detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the
Premature Ejaculation Treatment Market. According to report the global premature ejaculation treatment market is
projected to grow at a CAGR of 10.7% over the forecast period of 2017-2023. Erectile Ddysfunction (ED) and
Premature Eejaculation (PE) are the two most prevalent male sexual dysfunctions. The Global Study of Sexual
Attitudes and Behaviors and other sources suggests a global prevalence of PE of approximately 20-30% across all age
groups. Chances of sexual dysfunction increases with age, physical inactivity, smoking, diabetes, stress and prostate
concerns.
Worldwide approximately 100 million men are estimated to suffer from male sexual dysfunction. Rise in base of
population with sexual disorders, changing lifestyle habits such as smoking, and drinking alcohol and increasing
stress levels in the men due to the work life are some of the driving factors of this market. In addition, large number
of drugs under pipeline for FDA approval and introduction of novel techniques are further expected to boost the
market growth in the coming years.
Geographically, North America is the leading contributor to the market and is expected to retain its position during
the forecast period due to the presence of large number of geriatric population, and large base of patients with
sexual disorders. However, Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is
predominantly due to increased healthcare awareness, technological advancements, and growing awareness among
the population about the treatment options available in the market.
Companies profiled:
Janssen Pharmaceutica N. V. (a pharmaceutical company of Johnson and Johnson)
Infinium Global Research